WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012047813) MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/047813    International Application No.:    PCT/US2011/054637
Publication Date: 12.04.2012 International Filing Date: 03.10.2011
IPC:
A61K 31/44 (2006.01), A61F 2/00 (2006.01)
Applicants: ELIXIR MEDICAL CORPORATION [US/US]; 870 Hermosa Drive Sunnyvale, CA 94085 (US) (For All Designated States Except US).
YAN, John [US/US]; (US) (For US Only).
ZHENG, Xiaoxia [CN/US]; (US) (For US Only).
BHAT, Vinayak, D. [US/US]; (US) (For US Only)
Inventors: YAN, John; (US).
ZHENG, Xiaoxia; (US).
BHAT, Vinayak, D.; (US)
Agent: HESLIN, James, M.; Wilson Sonsini Goodrich & Rosati 650 Page Mill Road Palo Alto, CA 94304-1050 (US)
Priority Data:
61/389,422 04.10.2010 US
Title (EN) MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
(FR) COMPOSÉS MACROCYCLIQUES À BASE DE LACTONE ET LEURS PROCÉDÉS D'UTILISATION
Abstract: front page image
(EN)The present disclosure provides a device for intracorporeal use which comprises an implant or a temporary device and at least one source of myolimus or a derivative thereof. The present disclosure also provides a method of inhibiting cell proliferation, inflammation or cytokine production by systemic or local administration of a therapeutically effective amount of myolimus or a derivative thereof. Further included in the present disclosure is a method of treating an ophthalmic condition or disease by administering a therapeutically effective amount of myolimus or a derivative thereof.
(FR)La présente invention concerne un dispositif destiné à être utilisé à l'intérieur du corps comprenant un implant ou un dispositif temporaire et au moins une source de Myolimus ou un dérivé de celui-ci. L'invention concerne également un procédé d'inhibition de la prolifération cellulaire, de l'inflammation ou de la production de cytokines par le biais d'une administration systémique ou locale d'une quantité thérapeutiquement efficace de Myolimus ou d'un dérivé de celui-ci. L'invention concerne en outre un procédé de traitement d'un état pathologique ou d'une maladie ophtalmique par le biais de l'administration d'une quantité thérapeutiquement efficace de Myolimus ou d'un dérivé de celui-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)